Accurate predictionof interleukin-13 (IL-13)-inducingepitopesis crucial for advancing targeted therapies against allergic inflammation,the cytokine storm associated with severe COVID-19, and related disorders.Current epitope prediction methods, however, often exhibit limitationsin efficiency and accuracy. The gene discussed is IL13; the disease is COVID-19.